SILO — Silo Pharma Balance Sheet
0.000.00%
- $7.46m
- $1.20m
- $0.07m
Annual balance sheet for Silo Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1.13 | 10.3 | 11.4 | 7.67 | 7.08 |
| Net Total Receivables | 0.024 | 0 | 0.066 | 0 | — |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 1.43 | 10.4 | 11.6 | 7.68 | 7.11 |
| Net Intangible Assets | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 1.43 | 10.5 | 11.6 | 7.75 | 7.41 |
| Payable / Accrued | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.142 | 0.49 | 0.436 | 0.776 | 1.66 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 0.146 | 1.43 | 1.3 | 1.57 | 2.38 |
| Redeemable Preferred Stock | |||||
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 1.28 | 9.06 | 10.3 | 6.18 | 5.03 |
| Total Liabilities & Shareholders' Equity | 1.43 | 10.5 | 11.6 | 7.75 | 7.41 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |